Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach

ConclusionSimulations showed a single G ‐CSF administration 48 h after the end of each eribulin injection seems to be the optimal schedule to reduce eribulin‐induced neutropenia. However, the new administration scheme should be tested in real life to evaluate its pertinence.Trial registrationEudract 2015-001753-32, 2015/01/26.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research